Horizon Therapeutics

KRYSTEXXA

  1. Home
  2.  / 
  3. J Code
  4.  / KRYSTEXXA – J2507

Manufacturer:

Horizon Therapeutics

Name:

KRYSTEXXA

Category:

J Code

HCPCS:

J2507

NDC(s):

75987-0080-10,

Primary Type:

Rheumatologic

Route of Administration:

Intravenous

About:

KRYSTEXXA is a Rheumatologic drug manufactured by Horizon Therapeutics and administered via the Intravenous route of administration. The J Code: J2507 is aligned to the drug KRYSTEXXA.

Access Pricing and More By Registering